Celularity (CELUW) Cash & Equivalents (2018 - 2025)

Celularity (CELUW) has 8 years of Cash & Equivalents data on file, last reported at $6.2 million in Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $6.2 million, up 736.72% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.2 million (up 736.72% YoY), and the FY2025 annual result was $6.2 million, up 736.72% from the prior year.
• Cash & Equivalents advanced to $6.2 million in Q4 2025 per CELUW's latest filing, from $120000.0 in the prior quarter.
• Over five years, Cash & Equivalents peaked at $72.7 million in Q3 2021 and troughed at $211.0 in Q2 2021.
• A 5-year average of $13.8 million and a median of $1.4 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2021 and 2022: Cash & Equivalents tumbled 99.97% in 2021, then soared 18007482.94% in 2022.
• A 5-year view of Cash & Equivalents shows it stood at $37.2 million in 2021, then plunged by 62.5% to $14.0 million in 2022, then slumped by 98.37% to $227000.0 in 2023, then soared by 225.11% to $738000.0 in 2024, then surged by 736.72% to $6.2 million in 2025.
• Business Quant data shows CELUW's Cash & Equivalents at $6.2 million in Q4 2025, $120000.0 in Q3 2025, and $863000.0 in Q2 2025.